Literature DB >> 10527632

Disintegrin-like/cysteine-rich region of ADAM 12 is an active cell adhesion domain.

A Zolkiewska1.   

Abstract

ADAM (a disintegrin and metalloprotease) proteins contain structural homology to the P-III class of snake venom metalloproteases (SVMPs) and are postulated to function, by analogy to these SMVPs, as cell adhesion molecules. ADAM 12 has been implicated in fusion of myoblasts, but its mechanism of action is not known. Instead of the RGD-like cell-binding motif present in SVMP disintegrins, the disintegrin domain of ADAM 12 contains a unique SNS sequence and therefore its adhesive potential has been controversial. In this report we demonstrate that the disintegrin-like/cysteine-rich (DC) domain of ADAM 12 constitutes a functional cell adhesion domain. We have expressed the DC domain of mouse ADAM 12 in insect cells and shown that the recombinant protein supported adhesion of C2C12 myoblasts and NIH 3T3 fibroblasts in a divalent cation-dependent manner. A sulfhydryl-specific biotinylation reagent revealed, however, that the overall conformation and flexibility of the cell-binding region of ADAM 12 DC domain may be significantly different from those of the SVMP disintegrins. Moreover, the disulfide bond structure of the DC domain was critical for its function, as incubation of the recombinant protein with reducing agents abolished subsequent cell adhesion. Recombinant DC bound to C2C12 cells with high affinity (K(D) approximately 0.10 microM, total number of binding sites n approximately 4.6 x 10(5)/cell). Adhesive properties of the DC domain of ADAM 12 produced in insect cells were further confirmed by cell surface binding of the DC domain expressed in C2C12 cells and secreted to the medium, consistent with the role of ADAM 12 in cell-cell interactions and myoblast fusion. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10527632     DOI: 10.1006/excr.1999.4632

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  16 in total

1.  Metalloprotease-disintegrin ADAM 12 binds to the SH3 domain of Src and activates Src tyrosine kinase in C2C12 cells.

Authors:  Q Kang; Y Cao; A Zolkiewska
Journal:  Biochem J       Date:  2000-12-15       Impact factor: 3.857

2.  Metalloprotease-disintegrin ADAM 12 interacts with alpha-actinin-1.

Authors:  Y Cao; Q Kang; A Zolkiewska
Journal:  Biochem J       Date:  2001-07-15       Impact factor: 3.857

3.  Crystal structures of VAP1 reveal ADAMs' MDC domain architecture and its unique C-shaped scaffold.

Authors:  Soichi Takeda; Tomoko Igarashi; Hidezo Mori; Satohiko Araki
Journal:  EMBO J       Date:  2006-05-11       Impact factor: 11.598

4.  ADAM12 alleviates the skeletal muscle pathology in mdx dystrophic mice.

Authors:  Pauliina Kronqvist; Nobuko Kawaguchi; Reidar Albrechtsen; Xiufeng Xu; Henrik Daa Schrøder; Behzad Moghadaszadeh; Finn Cilius Nielsen; Camilla Fröhlich; Eva Engvall; Ulla M Wewer
Journal:  Am J Pathol       Date:  2002-11       Impact factor: 4.307

Review 5.  The regulatory role of Myomaker and Myomixer-Myomerger-Minion in muscle development and regeneration.

Authors:  Bide Chen; Wenjing You; Yizhen Wang; Tizhong Shan
Journal:  Cell Mol Life Sci       Date:  2019-10-23       Impact factor: 9.261

6.  Function of the cysteine-rich domain of the haemorrhagic metalloproteinase atrolysin A: targeting adhesion proteins collagen I and von Willebrand factor.

Authors:  Solange M T Serrano; Li-Guo Jia; Deyu Wang; John D Shannon; Jay W Fox
Journal:  Biochem J       Date:  2005-10-01       Impact factor: 3.857

7.  ADAM12 and alpha9beta1 integrin are instrumental in human myogenic cell differentiation.

Authors:  Peggy Lafuste; Corinne Sonnet; Bénédicte Chazaud; Patrick A Dreyfus; Romain K Gherardi; Ulla M Wewer; François-Jérôme Authier
Journal:  Mol Biol Cell       Date:  2004-12-01       Impact factor: 4.138

8.  Zinc metalloproteinases and amyloid Beta-Peptide metabolism: the positive side of proteolysis in Alzheimer's disease.

Authors:  Mallory Gough; Catherine Parr-Sturgess; Edward Parkin
Journal:  Biochem Res Int       Date:  2010-09-30

Review 9.  A disintegrin and metalloproteinase-12 (ADAM12): function, roles in disease progression, and clinical implications.

Authors:  Erin K Nyren-Erickson; Justin M Jones; D K Srivastava; Sanku Mallik
Journal:  Biochim Biophys Acta       Date:  2013-05-13

Review 10.  Role of ADAM and ADAMTS metalloproteinases in airway diseases.

Authors:  Genevieve Paulissen; Natacha Rocks; Maud M Gueders; Celine Crahay; Florence Quesada-Calvo; Sandrine Bekaert; Jonathan Hacha; Mehdi El Hour; Jean-Michel Foidart; Agnes Noel; Didier D Cataldo
Journal:  Respir Res       Date:  2009-12-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.